Reported risk factors for BM in BC patients include young age at first diagnosis, presence of lung metastases, short disease-free survival, hormone receptor (HR)-negative tumors, triple-negative tumor subtype, HER2 overexpression, and BRCA1 phenotype (2, 8, 10–15). The gene discussed is ERBB2; the disease is breast cancer.